http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1066235-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f84747e8d08b1023763356d0e7d1db68 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-07 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C43-178 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C43-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B59-001 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B59-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C43-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C43-178 |
| filingDate | 1999-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2003-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62c7015c9d6395beeda89b248383179c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd56b10eedf55a4dd0887b30ffe7806f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88e012be54bf77391d81cee20c5e83fb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3254992576e079dcc4d0ed0be2c98ecb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bdab841cc1fdb8869ba9504878bac2fa |
| publicationDate | 2003-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-1066235-B1 |
| titleOfInvention | Synthetic endogenous cannabinoid analogues and uses thereof |
| abstract | The present invention relates to a compound of the general formula (I) which is a non-hydrolysable analogue of endogenous cannabinoids, which are found to be more potent therapeutic agents as they are more stable, for example, to hydrolytic cleavage in the gastrointestinal tract. The cannabinoid analogues of the invention have a therapeutic value. Therefore, pharmaceutical compositions comprising as active ingredient a therapeutically effective amount of at least one compound of the invention may be prepared. Such compositions may be used as anti-inflammatory, anti-asthmatic, analgetic, hypotensive, antiemetic or anti-spasmodic compositions, and as compositions for treating and/or preventing glaucoma or migraine, or as compositions for relieving symptoms of multiple sclerosis and mood stimulating compositions. |
| priorityDate | 1998-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 134.